Literature DB >> 4873839

The effect of heterologous anti-lymphocytic serum on the small lymphocyte population of rats.

H D Agnew.   

Abstract

Treatment of Lewis strain rats with a single subcutaneous dose of rabbit anti-rat thymocyte serum (RARTS) resulted in a marked depletion of small lymphocytes in the blood and thoracic duct lymph for approximately 10 days. While the thoracic duct lymphocytes were declining in numbers, rabbit antibody could be detected on the surfaces of a high percentage of the lymph cells. Furthermore, the thoracic duct lymphocytes were unable to initiate graft vs. host reactions during the period of depletion, even when injected in extremely large doses. Approximately 2 wk after treatment, the numbers and immune competence of the small lymphocytes returned to normal.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4873839      PMCID: PMC2138510          DOI: 10.1084/jem.128.1.111

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  The fate of parental strain small lymphocytes in F1 hybrid rats.

Authors:  J L GOWANS
Journal:  Ann N Y Acad Sci       Date:  1962-10-24       Impact factor: 5.691

2.  Quantitative studies on the induction of tolerance of skin homografts and on runt disease in neonatal rats.

Authors:  R E BILLINGHAM; W K SILVERS; D STEINMULLER
Journal:  J Natl Cancer Inst       Date:  1962-02       Impact factor: 13.506

3.  Effect of antilymphocytic antibody and antibody fragments on skin-homograft survival and the blood-lymphocyte count in rats.

Authors:  N F Anderson; K James; M F Woodruff
Journal:  Lancet       Date:  1967-05-27       Impact factor: 79.321

4.  Some effects of purified heterologous antihuman lymphocyte serum in man.

Authors:  A P Monaco; M L Wood; P S Russell
Journal:  Transplantation       Date:  1967-07       Impact factor: 4.939

5.  Further experiments on the action of antilymphocytic antiserum.

Authors:  R H Levey; P B Medawar
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

6.  The relationship of lymphopenia production and lymphocyte agglutinating and cytotoxic antibody titers to the immunosuppressive potency of heterologous antilymphocyte plasma.

Authors:  H F Jeejeebhoy
Journal:  Transplantation       Date:  1967-07       Impact factor: 4.939

7.  Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties.

Authors:  J G Gray; A P Monaco; M L Wood; P S Russell
Journal:  J Immunol       Date:  1966-02       Impact factor: 5.422

8.  Nature and mode of action of antilymphocytic antiserum.

Authors:  R H Levey; P B Medawar
Journal:  Proc Natl Acad Sci U S A       Date:  1966-10       Impact factor: 11.205

9.  Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response.

Authors:  A P Monaco; M L Wood; J G Gray; P S Russell
Journal:  J Immunol       Date:  1966-02       Impact factor: 5.422

10.  The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type.

Authors:  B H WAKSMAN; S ARBOUYS; B G ARNASON
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

View more
  5 in total

Review 1.  The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives.

Authors:  E M Lance
Journal:  Clin Exp Immunol       Date:  1970-06       Impact factor: 4.330

2.  Anti-thymocyte serum effects on Plasmodium berghei infection in rats.

Authors:  D T Spira; P H Silverman; C Gaines
Journal:  Immunology       Date:  1970-11       Impact factor: 7.397

3.  Effects of heterologous antineutrophil serum in guinea pigs. Hematologic and ultrastructural observations.

Authors:  D M Simpson; R Ross
Journal:  Am J Pathol       Date:  1971-10       Impact factor: 4.307

4.  Suppressor activity of blood lymphocytes from guinea-pigs treated with ALS.

Authors:  W Rudnicka
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

5.  Studies on the immunotherapy of runt disease in rats.

Authors:  W K Silvers; R E Billingham
Journal:  J Exp Med       Date:  1969-04-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.